Does IRAP contribute to Alzheimer's Disease Pathology? [ 2013 - 2016 ]

Research Grant

Researchers: A/Pr Siew Yeen Chai (Principal investigator)

Brief description Alzheimer’s disease is a progressive brain disease which is results in memory loss and cell death. All currently prescribed drugs treat the memory loss but are unable to stop the deterioration of brain cells. We have developed a class of drugs that reverse memory loss. These drugs target a protein called insulin-regulated aminopeptidase, IRAP. We recently found that these drugs also reduce the disease pathology. This research proposal aims to investigate the role of IRAP in the initiation or progression of Alzheimer’s disease pathology.

Funding Amount $AUD 743,042.48

Funding Scheme Project Grants

Notes Standard Project Grant